Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
(2016)
Journal Article
Hardy, T., Zeybel, M., Day, C. P., Dipper, C., Masson, S., McPherson, S., …Mann, J. (2017). Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease. Gut, 66(7), 1321-1328. https://doi.org/10.1136/gutjnl-2016-311526
Objective: Liver biopsy is currently the most reliable way of evaluating liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Its inherent risks limit its widespread use. Differential liver DNA methylation of peroxisome prolifer... Read More about Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.